Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, February 17, 2021
Recro Pharma has announced key appointments to its management team and board of directors.
read more
Rentschler Biopharma SE announced the appointment of Dr. Dominik Kugelstadt as Head of Clinical and Commercial Manufacturing, Laupheim, on July 1, 2023.
read more
Tuesday, November 01, 2011
This advanced form of a highly purified novel vaccine, developed by a leading vaccine company in Japan promises to provide highly effective protection from a severely debilitating infection while exhibiting a superior patient safety profile.
read more
Twist Bioscience announced the appointment of Mark Daniels to the newly-created position of chief ethics and compliance officer.
read more
Wednesday, August 23, 2017
Trial By Fire Solutions has released SimpleTrials 2.0, a clinical trial management system (CTMS) with new features such as site contracts and payments management.
read more
Monday, December 18, 2017
PAREXEL has introduced its enhanced Global Data Operations solution.
read more
Pharmaceutical Product Development, LLC (PPD) today announced it has appointed David Johnston, Ph.D., as executive vice president of global laboratory services. Dr. Johnston directs PPD’s industry-leading, comprehensive laboratory services, including...
read more
Cryoport announced Novartis has signed an agreement contracting Cryoport over an initial three-year term for cryogenic logistics support of CTL019/CD19 CAR-T cell therapy.
read more
Exopharm Limited has signed a Master Collaborative Services Agreement (MSA) with the Astellas Institute for Regenerative Medicine (AIRM).
read more
Wednesday, December 16, 2020
Syneos Health and ConcertAI have announced a strategic collaboration to accelerate and streamline the implementation of novel oncology clinical trial research and study designs.
read more
The FDA awarded 15 new clinical trial research grants totaling more than $22 million to boost development of products for patients with rare diseases.
read more
Cobra Biologics, a leading contract manufacturer of clinical and commercial scale biologics and pharmaceuticals, and targeted cancer therapy company BioCancell have announced an agreement to manufacture BioCancell’s BC-821 cancer drug for clinical ...
read more
Thursday, November 21, 2024
NorthStar Medical Radioisotopes announced the signing of a strategic Master Supply Agreement with Cellectar Biosciences, Inc. under which Cellectar will acquire and integrate NorthStar’s n.c.a. Ac-225 into Cellectar’s proprietary Phospholipid Ethers ...
read more
Friday, December 20, 2013
The European Medicines Agency (EMA) has now reviewed all comments received on its draft policy on publication and access to clinical trial data. While the comments received showed that there is large support for the Agency’s plans to allow access to ...
read more
Thursday, November 02, 2017
Rho announced plans to build a new 159,000-square-foot headquarters building in Research Triangle Park, North Carolina.
read more